Navigation Links
Ariel Pharmaceuticals, Inc. Acquires Novel Compound for Acute Migraine
Date:9/21/2011

gs in acute care clinical indications to expeditiously build value for our shareholders."

Episodic migraine headaches affect more than 10% of the world population and are among the top four disabling neurological conditions.  Migraines account for an estimated 30 million days of lost productivity at a cost of up to $17 billion per year in the U.S.  Almost half of migraine patients suffer severe pain and require bed rest.  Currently, the most common migraine therapies are non-steroidal anti-inflammatory drugs (NSAIDs) and triptans (5-HTIB/1D agonists).  Shortcomings of these drugs include failure to work in a significant percentage of patients, slow speed of activity, recurrence of pain and potentially debilitating side effects, including cardiovascular and gastrointestinal toxicity.

About Ariel Pharmaceuticals, Inc.

Ariel Pharmaceuticals, Inc. is a private, specialty pharmaceutical company focused on the development and commercialization of drugs that improve quality of life for patients with acute neurological disorders and trauma.  Ariel is developing three drugs intended to meet unmet medical needs in migraine, hemorrhagic shock and post-operative cognitive decline.  The company's business strategy is based on in-licensing clinic-ready drugs in acute care clinical indications that have well-defined efficacy endpoints and where there is little to no competition in order to enable Ariel to rapidly build shareholder value.  For more information, please visit: www.arielpharma.com

Ariel Pharmaceuticals, Inc.
Steve Orndorff, PhD
President & CEO
sorndorff@arielpharma.com

Media Contact:
Tiberend Strategic Advisors, Inc.
(212) 827-0020
Andrew Mielach
amielach@tiberend.com
or
Jason Rando

SOURCE Ariel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ariel Ways GovBuys Awarded VA Contract
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
7. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
8. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
9. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Final shortlist announced, winners ... The second edition of the much-awaited VCCircle Healthcare Awards is ... the final nominations for the 2014 honours.  The names ... of September 25 at The Taj Mahal Palace, Mumbai ... a variety of qualitative and quantitative parameters - such ...
(Date:9/22/2014)... Research and Markets has announced the addition ... report to their offering. Worldwide ... despite the presence of many cholesterol-lowering drugs in the ... been ubiquitously prescribed over the last 25 years. Researchers ... is the cornerstone of assessing heart risk. Irrespective of ...
(Date:9/22/2014)... , Sept. 22, 2014  Continua and ... in healthcare technology, media and telecommunications,  have formed ... China and promote international ... BHG announced this new partnership during the global ... Washington, DC , while also ...
Breaking Medicine Technology:Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 2Recognising Impactful Healthcare Companies at VCCircle Healthcare Awards 2014 3PCSK9 and Other Novel Hypercholesterolemia Drugs 2PCSK9 and Other Novel Hypercholesterolemia Drugs 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... Medical Imaging today announced that the company has been ... Office covering technology for its COR Analyzer® System.  The ... Angiography (cCTA) studies to accelerate emergency department triage of ... and radiology department workflow. The System is marketed in ...
...   Shire plc (LSE: SHP, NASDAQ: ... that following the,satisfaction of the closing conditions, including the ... of 1976, the acquisition of Advanced BioHealing, Inc. ("ABH"),as ... The Advanced BioHealing business becomes part of ...
Cached Medicine Technology:Rcadia Medical Imaging Awarded Four U.S. Patents Covering Technology for Automated Analysis of Coronary CT Angiography 2Shire Completes Acquisition of Advanced BioHealing, Inc. 2
(Date:9/22/2014)... patients undergoing breast cancer surgery require additional operations because ... in the initial operation. However, researchers at Brigham and ... developed that will help surgeons better distinguish cancerous breast ... repeat operations. , The study is ... the Proceedings of the National Academy of Sciences ...
(Date:9/22/2014)... PITTSBURGH, PA (PRWEB) September 22, 2014 ... caring for patients to the problem of side-sleeping. "My ... my side, so I designed a solution to this ... fall asleep comfortably than to have your arm 'fall ... sleep on his or her side more comfortably. It ...
(Date:9/22/2014)... London, UK (PRWEB) September 22, 2014 ... growth in the recent years. The statistically important data ... and safety of cancer vaccines. The primary challenge to ... sufficient information about the exact mechanism of how a ... leads to various results in different individuals owing to ...
(Date:9/22/2014)... Barbara Bronson Gray HealthDay Reporter ... every pregnant woman wonders: What can I do to help ... iron supplements as prescribed may play a role in reducing ... (ASD). The researchers found that mothers of children with ... before and during pregnancy than those whose children seem to ...
(Date:9/22/2014)... Diego CA (PRWEB) September 22, 2014 ... significantly expand its work to equip women around the ... on poverty. Through the Women Empowered (WE) Initiative ... will now join community-led groups to pool their savings, ... , “Women are the solution to ending poverty in ...
Breaking Medicine News(10 mins):Health News:The fine line between breast cancer and normal tissues 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 2Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 3Health News:World Cancer Vaccines Market Landscape Examined by Kuick Research in New Study Published at MarketPublishers.com 4Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3
... has warned about the inherent risks involved in the ... ,The human milk is capable of causing food ... chances that the human milk carries remnants of drugs ... unhygienic storage of milk, and not adhering to hygienic ...
... health care workers in the United States has risen, ... settings.// ,According to Vanderbilt infectious disease experts ... treatment should be provided to health care workers with ... skin test, particularly if they meet certain high-risk criteria. ...
... company Venus Remedies Ltd today said it has ... latest antibiotic fixed dose combination used in the ... new antibiotic combination, active against multi-resistant strains of ... a broad-spectrum coverage of bactericidal activity, it informed ...
... to seek help from a doctor or mental health professional, ... it difficult to obtain adequate// treatment or medication, according to ... to treatment for people with suicide ideation," said Ruth Klap, ... and study co-author. "There is a problem with perceived need ...
... orphans and vulnerable children (OVC) need to be prioritized in ... report, 'A Call to Action: Children, the Missing Face of ... of children and also to realize the targets chartered in ... maternal health, for the year 2015. ,Anti –AIDs ...
... by most Britons are packed with dust mites, fungus and skin ... was found to contain up to 20,000 live house dust mites ... an 11-year unwashed duvet revealed over an ounce and a half ... ,In addition it was found that more than four in ...
Cached Medicine News:Health News:Many Suicidal Adults Aren't Getting Mental Health Treatment 2Health News:Dust mites use Duvets as their Haven 2
... innovative stent allows the physician to intubate the ... with just topical anesthetic drops., ,The SRS is ... in three lengths 25mm, 30mm and 35mm (disposable ... stent is an anchor-shaped head to provide fixation. ...
... or somatomedin-C, is a peptide highly dependent ... promoting activity. IGF-I is transported in serum ... of growth disorders, measurements of IGF-I are ... hormone secretion. A normal plasma or serum ...
... is a high-throughput immunoassay system built around ... 2000 with the important addition of Logic ... to be designed for optimal performance with ... for critical assays such as the cardiac ...
... For The Detection ... Uses Of C-Peptide Measurement:, ... fasting hypoglycemia , Assisting ... diabetes mellitus , Differentiating ...
Medicine Products: